Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
about
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsNon-alcoholic fatty liver disease: what the clinician needs to know.The Natural Course of Non-Alcoholic Fatty Liver DiseaseThe Immune Landscape in Nonalcoholic Steatohepatitis.Diet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetThe Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver DiseaseManagement of non-alcoholic fatty liver disease in 2015Bile acid receptors and nonalcoholic fatty liver diseaseNonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment StrategyDiagnosis and Management of Alcoholic Liver DiseaseObesity and liver transplantationNon-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatmentInsulin resistance in clinical and experimental alcoholic liver diseaseThe Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know.A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- miceHepatocellular carcinoma in patients with non-alcoholic fatty liver diseaseIron and non-alcoholic fatty liver diseaseMetabolic complications in liver transplant recipientsCardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective studyThe Flexibility of Ectopic LipidsLiver grafts from hepatitis B surface antigen-positive donors: A review of the literaturePrevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populationsDifferential intrahepatic phospholipid zonation in simple steatosis and nonalcoholic steatohepatitisImpact of body mass index on outcomes of 48281 patients undergoing first time cadaveric liver transplantationLiraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trialPerspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future TherapiesNon-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.NAFLD and liver transplantation: Current burden and expected challenges.Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock?Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis.Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis.Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis.Cost-utility analysis of nonalcoholic steatohepatitis screening.Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)Underestimation of liver-related mortality in the United States.Effects of resveratrol in experimental and clinical non-alcoholic fatty liver diseaseBenefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients.Proteinuria and baseline renal function predict mortality and renal outcomes after sirolimus therapy in liver transplantation recipients.
P2860
Q22299426-83FC35B8-0DB2-46E6-878A-947E9C8D3AD1Q24563068-8904511C-EC86-418A-853C-36225A38F352Q26746947-B5AE4836-1864-464C-B1E2-22216889D2B5Q26747323-D201D4C0-DFF3-495C-AC75-F35CB9A2DA31Q26752614-8C760D8D-F44E-41AF-A148-CE27D9BC2B84Q26752762-722532DA-F6BB-45DB-9203-2C043A5EA226Q26771148-39CADEFF-4617-41FF-B7DA-3EE1F13E8415Q26775814-45BFD1E1-7099-4E73-BE2C-6DD150224304Q26781753-B2023FCA-5036-4EC9-B1FC-140090D38DE2Q26781876-575805C3-6532-4C87-A7D9-0080E5B73BA0Q26784097-0B7E4A10-F57E-4261-9E94-93B0B2A0AD08Q26852019-6136BCE9-5D41-449E-91A4-BB1097744702Q26865988-E042FEA2-7607-441B-9B13-E06F7F2C9A17Q27008277-29F3B09F-C3B5-4760-A67E-2FEF1F2ED1D6Q27339224-D35D0A4C-84D8-4F36-800C-4546C225DA1BQ28066100-114D27F9-6506-4354-83F2-2C383A3D532FQ28070303-C35B9863-EB22-49AD-87F7-E4AFA1A8C8F9Q28073134-591EC8F3-6590-4E68-B709-30C2A607852CQ28074308-CBB49227-FB7E-4002-B739-8F8DE792E5AFQ28076063-5AD04EC4-25B7-470B-9892-B3CA29A2941DQ28080109-1ACA4F42-C13C-4178-82EF-E16F1DE3D915Q28384968-E79C8546-7635-4404-9EA3-BB1B1904DD8CQ28386598-15F9C0C5-1E03-4FD5-9606-08435882F4B0Q28486701-96AAABAC-098E-44FC-A99F-A6A26F18BA05Q28597400-570B5CEB-E0C8-4CCB-B7B4-B70E0272A3BDQ28661700-C3D5B208-F6E9-4F91-BD8F-2355B67C5FFEQ30234444-6FF941EA-F5DB-4BB7-9972-E787AF142350Q30235846-04A654E8-0F83-47EA-BCEA-9C900DB7C3EAQ30241387-3FCADA1E-8563-45CF-AADD-69C9F4CB8AE2Q30248646-33CB121E-ACA9-490D-B263-F0103F4770E2Q30252463-0CA8EB66-D5D1-4DD2-A2A8-7B3FB7E8EDCBQ30274723-21199BBA-D006-47CA-BA1E-082AE8EAFC05Q30300233-04CE6DC3-0108-40F9-9F62-AB02A3B84209Q30365017-94069D61-0FAE-4984-A81D-27A84916A807Q30385602-209CB693-C62D-43D6-BD05-90BBB93CFA6DQ30413592-E48832CA-70FE-4668-9051-57DC52CDA446Q30564165-DE8BA778-278B-4D16-B8C9-C6852ABE9E4CQ33563877-D99CE428-BC28-43C5-9793-805A0C7C63CBQ33573638-7CDA9D0E-132A-40AE-92D2-73406B44E1CEQ33587143-BF4847A3-17B0-4052-8CD7-D3BD0D441DF5
P2860
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Frequency and outcomes of live ...... epatitis in the United States.
@en
Frequency and outcomes of live ...... epatitis in the United States.
@nl
type
label
Frequency and outcomes of live ...... epatitis in the United States.
@en
Frequency and outcomes of live ...... epatitis in the United States.
@nl
prefLabel
Frequency and outcomes of live ...... epatitis in the United States.
@en
Frequency and outcomes of live ...... epatitis in the United States.
@nl
P2093
P1433
P1476
Frequency and outcomes of live ...... epatitis in the United States.
@en
P2093
Julie K Heimbach
Justin M Burns
Kymberly D Watt
Michael R Charlton
Rachel A Pedersen
Ross A Dierkhising
P304
P356
10.1053/J.GASTRO.2011.06.061
P407
P577
2011-07-02T00:00:00Z